ABSTRACT
Microwave ablation is a developing treatment option for unresectable lung cancer.
Early experience suggests that it may have advantages over radiofrequency (RF) ablation
with larger ablation zones, shorter heating times, less susceptibility to heat sink,
effectiveness in charred lung, synergism with multiple applicators, no need for grounding
pads, and similar survival benefit. Newer microwave ablation devices are being developed
and as their use becomes more prevalent, a greater understanding of device limitations
and complications are important. Herein we describe a microwave lung ablation complicated
by bronchocutaneous fistula (BCF) and its treatment. BCF treatment options include
close monitoring, surgical closure, percutaneous sealant injection, and endoscopic
plug or sealant in those who are not surgical candidates.
KEYWORDS
Microwave ablation - bronchopleural fistula - lung cancer treatment
REFERENCES
- 1 WHO .International Agency for Research on Cancer. GLOBOCAN 2008. Lyon, France: WHO;
2010
- 2
Dupuy D E, Zagoria R J, Akerley W, Mayo-Smith W W, Kavanagh P V, Safran H.
Percutaneous radiofrequency ablation of malignancies in the lung.
AJR Am J Roentgenol.
2000;
174
(1)
57-59
- 3
Chan V O, McDermott S, Malone D E, Dodd J D.
Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature
using evidence-based techniques.
J Thorac Imaging.
2011 Feb;
26
(1)
18-26
- 4
Lencioni R, Crocetti L, Cioni R et al..
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat,
multicentre clinical trial (the RAPTURE study).
Lancet Oncol.
2008;
9
(7)
621-628
- 5
Simon C J, Dupuy D E, DiPetrillo T A et al..
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Radiology.
2007;
243
(1)
268-275
- 6
Wolf F J, Grand D J, Machan J T, Dipetrillo T A, Mayo-Smith W W, Dupuy D E.
Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in
50 patients.
Radiology.
2008;
247
(3)
871-879
- 7
Lubner M G, Brace C L, Hinshaw J L, Lee Jr FT.
Microwave tumor ablation: mechanism of action, clinical results, and devices.
J Vasc Interv Radiol.
2010;
21
(8 Suppl)
S192-203
- 8
Radvany M G, Allan P F, Frey W C, Banks K P, Malave D.
Pulmonary radiofrequency ablation complicated by subcutaneous emphysema and pneumomediastinum
treated with fibrin sealant injection.
AJR Am J Roentgenol.
2005;
185
(4)
894-898
- 9
Okuma T, Matsuoka T, Yamamoto A et al..
Frequency and risk factors of various complications after computed tomography-guided
radiofrequency ablation of lung tumors.
Cardiovasc Intervent Radiol.
2008;
31
(1)
122-130
- 10
Pua B B, Thornton R H, Solomon S B.
Ablation of pulmonary malignancy: current status.
J Vasc Interv Radiol.
2010;
21
(8, Suppl)
S223-S232
Review
- 11
Abu-Hijleh M, Blundin M.
Emergency use of an endobronchial one-way valve in the management of severe air leak
and massive subcutaneous emphysema.
Lung.
2010;
188
(3)
253-257
- 12
Lois M, Noppen M.
Bronchopleural fistulas: an overview of the problem with special focus on endoscopic
management.
Chest.
2005;
128
(6)
3955-3965
- 13
Baumann M H, Strange C, Heffner J E AACP Pneumothorax Consensus Group et al.
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi
consensus statement.
Chest.
2001;
119
(2)
590-602
- 14
Sakurai J, Hiraki T, Mukai T et al..
Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation
of lung tumors.
J Vasc Interv Radiol.
2007;
18
(1 Pt 1)
141-145
James T BuiM.D.
Section of Interventional Radiology, Department of Radiology, University of Illinois
Medical Center
1740 West Taylor Street, MC 931, Chicago, IL 60612
Email: jtbui@uic.edu
